Long-term pharmacokinetics of mycophenolate mofetil (MF) suspension in pediatric renal transplant recipients.

被引：0
|
作者：
Weber, LT
Hoecker, B
Bunchman, T
Rashford, M
Toenshoff, B
机构：
[1] Univ Childrens Hosp, Heidelberg, Germany
[2] DeVos Childrens Hosp, Grand Rapids, MI USA
[3] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源：
PEDIATRIC TRANSPLANTATION | 2005年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
83
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Long-term pharmacokinetics of mycophenolate mofetil (MMF) suspension in pediatric renal transplant recipients: 3-year results from the prospective tricontinental trial
    Weber, LT
    Hoecker, B
    Bunchman, T
    Rashford, M
    Toenshoff, B
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 402 - 402
  • [2] Long-Term Mycophenolate Mofetil Treatment in Pediatric Renal Transplant Patients
    Roberts, John P.
    Potter, Donald
    Bouw, M. Rene
    [J]. DIALYSIS & TRANSPLANTATION, 2009, 38 (11) : 445 - +
  • [3] Long-term (3 years) pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients.
    Weber, Lutz T.
    Hoecker, Britta
    Armstrong, Victor W.
    Oellerich, Michael
    Toenshoff, Burkhardt
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 366 - 366
  • [4] Long-term benefits and efficacy of maintenance immunosuppression with mycophenolate mofetil in heart transplant recipients.
    Dandel, M
    Lehmkuhl, H
    Knosalla, C
    Grauhan, O
    Hetzer, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 172 - 172
  • [5] Withdrawal of Mycophenolate Mofetil in stable renal transplant recipients.
    Meier-Kriesche, HU
    Kaza, H
    Thambuganipalle, R
    Vaghela, M
    Jacobs, HG
    Mulgaonkar, SP
    Friedman, GS
    Kaplan, B
    [J]. TRANSPLANTATION, 2000, 69 (08) : S132 - S132
  • [6] Evaluation of Mycophenolate Mofetil Exposure in Renal Transplant Recipients.
    Ott, M. C.
    Mietz, S.
    Chang, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1109 - 1109
  • [7] Cyclosporin changes the pharmacokinetics of mycophenolate mofetil in kidney transplant recipients.
    Gregoor, PJHS
    Hesse, CJ
    van der Mast, BJ
    IJzermans, JNM
    Weimar, W
    van Gelder, T
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1164 - 1164
  • [8] Pharmacokinetics and Immunodynamics of Basiliximab in Pediatric Renal Transplant Recipients on Mycophenolate Mofetil Comedication
    Hoecker, Britta
    Kovarik, John M.
    Daniel, Volker
    Opelz, Gerhard
    Fehrenbach, Henry
    Holder, Martin
    Hoppe, Bernd
    Hoyer, Peter
    Jungraithmayr, Therese C.
    Koepf-Shakib, Sabine
    Laube, Guido F.
    Mueller-Wiefel, Dirk E.
    Offner, Gisela
    Plank, Christian
    Schroeder, Monika
    Weber, Lutz T.
    Zimmerhackl, Lothar B.
    Toenshoff, Burkhard
    [J]. TRANSPLANTATION, 2008, 86 (09) : 1234 - 1240
  • [9] Long-term efficacy and safety of mycophenolate mofetil with tacrolimus in orthotopic (OLT) liver transplant recipients.
    Holt, CD
    Ghobrial, MM
    Sievers, TM
    Farmer, DM
    Saab, S
    McDiarmis, SV
    Busuttil, RW
    [J]. LIVER TRANSPLANTATION, 2005, 11 (07) : C45 - C45
  • [10] Conversion to mycophenolate mofetil (MMF) in pediatric kidney transplant recipients.
    Machado, PGP
    Nogueira, PCK
    Park, SI
    Tedesco-Silva, H
    Pestana, JOM
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 92 - 92
12345